DrugDashboards

Oseltamivir Phosphate

Oseltamivir · OSELTAMIVIR PHOSPHATE 30 mg/1 · Capsule · Oral · AvKARE

NDC 42291-0666-10 · 10 CAPSULE in 1 BOX, UNIT-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$3.03per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$6.94per unitAvKare, LLC · Aug 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$78.16
Reported to Texas DSHS · 2026 annual filing · AvKare

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for oseltamivir (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA209093
TE code
AB
Approval date
May 17, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Oseltamivir (Capsule)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals NY LLCOSELTAMIVIR PHOSPHATE 45 mg/1Jul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals NY LLCOSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 3, 2026
Alembic Pharmaceuticals Inc.OSELTAMIVIR PHOSPHATE 30 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.OSELTAMIVIR PHOSPHATE 45 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.OSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedOSELTAMIVIR PHOSPHATE 30 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedOSELTAMIVIR PHOSPHATE 45 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedOSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOSELTAMIVIR PHOSPHATE 75 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOSELTAMIVIR PHOSPHATE 30 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCOSELTAMIVIR PHOSPHATE 30 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Oseltamivir Phosphate — NDC 42291-0666-10," retrieved September 3, 2026, https://drugdashboards.com/drug/42291066610.

Free to cite with attribution — see how the data is put together.